Efficacy and safety of letermovir prophylaxis for cytomegalovirus infection after hematopoietic stem cell transplantation

MLA

Wen-Wen Li, et al. “Efficacy and Safety of Letermovir Prophylaxis for Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation.” Blood Science, vol. 6, no. 1, Jan. 2024, p. e00178. EBSCOhost, https://doi.org/10.1097/BS9.0000000000000178.

APA

Wen-Wen Li, Yong-Mei Zhang, Meng-Zhu Shen, & Xiao-Dong Mo. (2024). Efficacy and safety of letermovir prophylaxis for cytomegalovirus infection after hematopoietic stem cell transplantation. Blood Science, 6(1), e00178. https://doi.org/10.1097/BS9.0000000000000178

Chicago

Wen-Wen Li, Yong-Mei Zhang, Meng-Zhu Shen, and Xiao-Dong Mo. 2024. “Efficacy and Safety of Letermovir Prophylaxis for Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation.” Blood Science 6 (1): e00178. doi:10.1097/BS9.0000000000000178.